Assessing Cognitive Decline at Home
Automatic Assessment of Neuropsychiatric Symptoms at Home Predictive of Mental Health and Cognitive Disorders Using Non-Intrusive Ambient Intelligence Technologies
1 other identifier
observational
25
1 country
1
Brief Summary
Neuropsychiatric symptoms (NPS) refer to a range of mental and emotional issues that can be observed through how patients move, perform daily tasks, and express feelings on their faces. In this study, the investigators want to find ways to accurately and unobtrusively track these symptoms in people's homes over time. Our goals are to note when these symptoms happen, predict potential problems, and gather clear data to help doctors make accurate diagnoses. To do this, the investigators will first collect information from participants who have in-home sensors. the investigators will then use special computer programs that can recognize everyday activities and identify features that connect to scores from the Mild Behavioral Impairment Checklist (MBI-C). These scores will be compared to a questionnaire (NPIQ) filled out by caregivers or family members, along with any relevant information from doctors about the patients' symptoms. The investigators aim to see how these features can help differentiate between types of NPS, such as mood changes and agitation. Finally, the investigators will create a dashboard for doctors that summarizes the patterns of these symptoms in patients, making it easier to monitor and manage their mental health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 21, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
ExpectedMay 18, 2026
April 1, 2026
1.1 years
November 21, 2024
May 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
develop a personalized and clinically interpretable NPS assessment system
Assessing NPS relies primarily on clinician observation \& interviews with caregivers, usually within brief \& infrequent clinical visits. Precise assessment and monitoring methods would incorporate objective, patient- \& caregiver-friendly, real-time tools and provide reliable \& frequently captured data. We aim to create a system that can monitoring individual and subsyndromes of NPS; and detect early changes in NPS by automatically quantifying \& detecting relevant behavioral abnormalities based on both intra- \& inter-individual comparisons. Our approach is a video sensor, information processing, \& alert system that utilizes in-home cameras \& ambient sensors with video features that can recognize \& track behaviors securely, pre-defines domains involved in a behavior; personalizes the results by assessing the individual's behavioral norms and the home environment; and analyzes, learns, and provides explainable items from different modalities of data: time, location, video, and audio.
2 year
NPS Clinical Dashboard
Overall, the investigators envision the clinical dashboard as a transformative tool that delivers clear and comprehensive data on each individual. Therefore enhancing the quality of diagnosis of NPS for individuals, leading to better patient interventions and more effective long term management strategies.
1 year
Secondary Outcomes (1)
generate Data and support for a large-scale study or clinical trial within the context of an R01.
2 years
Eligibility Criteria
Older Adults - 65+
You may qualify if:
- Age 65+ years old
- Any age and ethnicity.
- With or without, or at risk of mild to moderate dementia and healthy controls.
- Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be)
You may not qualify if:
- Those with severe mobility impairments
- participants in non-home settings (skilled nursing facilities, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- Johns Hopkins Universitycollaborator
- University of Rochestercollaborator
Study Sites (1)
Clinical Excellence Research Center
Palo Alto, California, 94304, United States
Related Publications (1)
Gould CE, Davis CH, Schuz N, Lin FV, Samus QM, Terada T, Daniel M, Tee S, Adeli E. Designing AI-Enabled Video Monitoring Clinician Dashboard for Neuropsychiatric Symptoms: A Survey of User Needs. Am J Geriatr Psychiatry Open Sci Educ Pract. 2026 Mar;9:46-51. doi: 10.1016/j.osep.2026.01.001. Epub 2026 Feb 8.
PMID: 41987876RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ehsan Adeli, PhD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Professor
Study Record Dates
First Submitted
November 21, 2024
First Posted
November 26, 2024
Study Start
October 1, 2024
Primary Completion
October 30, 2025
Study Completion (Estimated)
December 30, 2026
Last Updated
May 18, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share